Orchard Therapeutics plc PEG Ratio

Orchard Therapeutics plc posts a PEG ratio of 106.34. That is above the Healthcare sector average of 11.52. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For Healthcare stocks, a PEG ratio near 11.52 is typical. Orchard Therapeutics plc's 106.34 is higher that level. That is roughly 823.4% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Orchard Therapeutics plc's PEG ratio of 106.34 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.

Context for ORTX's PEG ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 11.52), and (3) consistency with growth and profitability. This page covers the first two; Orchard Therapeutics plc's other metric pages and overview cover the third.

Judging Orchard Therapeutics plc against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in PEG ratio easier to interpret. Start with 106.34 here, then scan peer and history charts to see if the gap is persistent.